STK11 and ovarian cancer: Deletion of NUAK1 or STK11 (encoding LKB1) was each identified as synthetic lethal with PTEN loss in breast cancer [13], and loss of either NUAK1 or STK11 drives a requirement for increased NFκB activity in ovarian cancer, again linked to suppression of oxidative stress [14].